{"organizations": [], "uuid": "39f87f74f96eefa275224d19cd4ba64614b323aa", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/12/business-wire-alexion-to-report-first-quarter-2018-results-on-thursday-april-26-2018.html", "country": "US", "domain_rank": 767, "title": "Alexion to Report First Quarter 2018 Results on Thursday, April 26, 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.041, "site_type": "news", "published": "2018-04-12T18:00:00.000+03:00", "replies_count": 0, "uuid": "39f87f74f96eefa275224d19cd4ba64614b323aa"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/12/business-wire-alexion-to-report-first-quarter-2018-results-on-thursday-april-26-2018.html", "ord_in_thread": 0, "title": "Alexion to Report First Quarter 2018 Results on Thursday, April 26, 2018", "locations": [], "entities": {"persons": [{"name": "susan altschuller", "sentiment": "none"}], "locations": [{"name": "conn.", "sentiment": "none"}, {"name": "usa", "sentiment": "none"}, {"name": "us", "sentiment": "none"}], "organizations": [{"name": "alexion", "sentiment": "negative"}, {"name": "alexion pharmaceuticals, inc.", "sentiment": "neutral"}, {"name": "alexion pharmaceuticals, inc", "sentiment": "none"}, {"name": "company", "sentiment": "none"}, {"name": "alexion pharmaceuticals", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "NEW HAVEN, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the first quarter ended March 31, 2018 on Thursday, April 26, 2018 before the US financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and audio webcast on Thursday, April 26, 2018, at 10:00 a.m. Eastern Time (ET).\nTo participate in this conference call, dial 888-394-8218 (USA) or 323-701-0225 (International), passcode 1013806 shortly before 10:00 a.m. ET. A replay of the call will be available from 1:00 p.m. ET through a limited time thereafter. The replay number is 888-203-1112 (USA) or 719-457-0820 (International), passcode 1013806. The audio webcast can be accessed on the Investor page of http://ir.alexion.com .\n[ALXN-G]\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180412005256/en/\nAlexion Pharmaceuticals, Inc.\nInvestors\nSusan Altschuller, Ph.D.\nVice President, Investor Relations\n(475) 230-3534\nSource: Alexion Pharmaceuticals, Inc.", "external_links": ["http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fir.alexion.com&esheet=51787461&newsitemid=20180412005256&lan=en-US&anchor=http%3A%2F%2Fir.alexion.com&index=1&md5=68de6bdee332fb72d3f622a9ff86fa76", "https://www.businesswire.com/news/home/20180412005256/en/"], "published": "2018-04-12T18:00:00.000+03:00", "crawled": "2018-04-12T19:08:34.006+03:00", "highlightTitle": ""}